We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$612M
AUM Growth
+$115M
Cap. Flow
+$88.3M
Cap. Flow %
14.44%
Top 10 Hldgs %
8.98%
Holding
532
New
97
Increased
238
Reduced
88
Closed
80

Top Buys

Rank Stock Value
1
TEO icon
Telecom Argentina
TEO
+$2.03M
2
MEOH icon
Methanex
MEOH
+$1.43M
3
EQM
EQM Midstream Partners, LP
EQM
+$1.32M
4
CGBD icon
Carlyle Secured Lending
CGBD
+$1.31M
5
GEO icon
The GEO Group
GEO
+$1.3M

Top Sells

Rank Stock Value
1
OXSQ icon
Oxford Square Capital
OXSQ
+$2.73M
2
MPLX icon
MPLX
MPLX
+$1.51M
3
MDCO
Medicines Co
MDCO
+$982K
4
GAIN icon
Gladstone Investment Corp
GAIN
+$857K
5
CELG
Celgene Corp
CELG
+$712K

Sector Composition

Rank Sector Weight
1 Financials 20.46%
2 Real Estate 16.88%
3 Energy 14.34%
4 Healthcare 10.85%
5 Materials 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BOLD
526
DELISTED
Audentes Therapeutics, Inc
BOLD
– –
-6,682
Closed -$188K
MDCO
527
DELISTED
Medicines Co
MDCO
– –
-19,635
Closed -$982K
VIAB
528
DELISTED
Viacom Inc. Class B
VIAB
– –
-407
Closed -$10K
ALDR
529
DELISTED
Alder Biopharmaceuticals
ALDR
– –
-20,985
Closed -$396K
SBNY
530
DELISTED
Signature Bank
SBNY
– –
-101
Closed -$12K
CELG
531
DELISTED
Celgene Corp
CELG
– –
-7,171
Closed -$712K
LJPC
532
DELISTED
La Jolla Pharmaceutical Company
LJPC
– –
-26,021
Closed -$229K
18 19 20 21
22

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, Virtus ETF Advisers held 532 positions worth $612M, up 23% from $496M the previous quarter. Its ten largest holdings account for 9% of the portfolio.

Virtus ETF Advisers deployed $88.3M of net new capital in Q4 2019, opening 97 new positions and adding to 238 existing holdings. Its largest new stake was Odonate Therapeutics, Inc. Common Stock: 14,229 shares worth $462K.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 24% a quarter earlier, followed by Real Estate and Energy.

On the sell side, the largest reduction was Oxford Square Capital, an estimated $2.73M trimmed.

  • Virtus ETF Advisers's largest Q4 2019 buy was Odonate Therapeutics, Inc. Common Stock: 14,229 shares worth $462K.
  • Virtus ETF Advisers added most to Telecom Argentina in Q4 2019, an estimated $2.03M increase.
  • Virtus ETF Advisers's biggest Q4 2019 reduction was Oxford Square Capital, cutting an estimated $2.73M.
  • Virtus ETF Advisers fully exited Medicines Co in Q4 2019, selling an estimated $982K.
  • Virtus ETF Advisers's ten largest holdings make up 9% of its $612M portfolio in Q4 2019.
  • Virtus ETF Advisers opened 97 new positions and closed 80 in Q4 2019.
  • Virtus ETF Advisers's portfolio value rose 23% quarter-over-quarter to $612M.

Based on Virtus ETF Advisers's 13F filing for Q4 2019, filed 13 Feb 2020.